ReviewNanomedicine (London, England)2025
Advancements in hydrogel applications for osteoarthritis therapy.
Review in Nanomedicine (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nanotherapeutic Strategies for Osteoarthritis: Targeting Aging, Metabolism and Inflammation.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoarthritis (OA) is a prevalent degenerative joint disorder that significantly impacts patient quality of life. Conventional interventions, including pharmacological and surgical approaches, have demonstrated numerous limitations and are inadequate for cartilage regeneration. Recently, hydrogels, as biomaterials characterized by a distinctive three-dimensional network structure, superior biocompatibility, and adjustable mechanical properties, have shown promising potential in OA therapy. In January 2025, a literature review was performed on hydrogel research published between January 2020 and January 2025, utilizing PubMed and Web of Science databases. Due to the foundational and representative nature of the experimental methodologies, two seminal original research articles from 2017 and 2019 were explicitly cited. This article reviews the latest advancements in hydrogel-based OA treatments, focusing on innovative therapeutic strategies such as lubrication enhancement, anti-inflammatory effects, microenvironmental response activation, mesenchymal stem cells and their exosome derivatives, as well as piezoelectric smart hydrogels, with particular emphasis on their application in OA management. Finally, we summarize the clinical research and development of hydrogel products from 2015 to 2025. Despite challenges in OA treatment, such as precise drug delivery and mechanical durability, the potential of hydrogels in personalized medicine and improving therapeutic outcomes positions them as a pivotal direction for future OA therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.